StockData
10x Genomics, Inc. logo

10x Genomics, Inc. (TXG) income statement

TXGNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 9/3099% above fair value
$51.80−5.58 (-9.72%)

Close on Nov 20, 2026Market cap $6.75BP/E –Yield –

See a number that looks wrong?